- Telehealth Visits
- Insurance plan information
Michael Waul, MD
Dermatology- Telehealth Visits
- Insurance plan information
Michael Waul, MD
Dermatology- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Dermatology, American Board of Dermatology
Residency
- Dermatology, University of CA at San Francisco- Dermatology GME
Internship
- Internal Medicine, Mount Auburn Hospital
Degree
- MD, Harvard Medical School
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 101 reviews
- June 26, 20265 out of 5 Stars
Dr. Waul provides exceptional care, and his demeanor is warm and comforting.
- June 26, 20265 out of 5 Stars
Dr. Michael Waul is phenomenal. I met him at a free skin cancer screening years ago and when the dermatologist asked me "is it OK if a resident can watch as I conduct a cancer screening on you?" And I say "yes". And the rest is history. Dr. Waul is professional, kind, a great listener and puts me at ease and answers my questions regarding skin cancer. A very good and trusted doctor.
- June 23, 20265 out of 5 Stars
I already have my husband lined up with Dr. Waul.
- June 11, 20265 out of 5 Stars
He has been the most empathetic and supportive dr I've had for my care.
- May 27, 20261.8 out of 5 Stars
Dr seemed rushed, was not clear in explanations, did not appear to care or show concern, and did not provide clear follow up.
- May 18, 20265 out of 5 Stars
I would highly recommend Dr. Waul. Excellent listener, excellent follow-up questions, good bedside manner and he made me feel very comfortable.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.